MedPath

The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

Completed
Conditions
Pediatric ALL
Fluid Overload
Registration Number
NCT05992246
Lead Sponsor
Tanta University
Brief Summary

The hypothesis of the study will be that the ratio of femoral vein diameter to femoral artery diameter will have correlation with fluid status in pediatrics.

Detailed Description

Proper administration of intravenous fluids is an important part of treating circulatory failure in children and affects the clinical outcome of the management of the child's emergency. Giving a small amount of fluid will cause tissue hypoperfusion and worsen organ dysfunction and cause ischemia. On the other hand, excess fluid interferes with oxygen delivary, exacerbates treatment outcomes, increases complications, and extends both the length of the stay in intensive care and mortality. The use of bedside ultrasound by pediatric intensive care physicians has become so critical in recent years that it is now a component of physical examination in ICUs

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • children with American society of anaesthesiologist physical status 1-2
  • 2-10 years of age
  • scheduled for elective surgery
  • signs of moderate to severe dehydration
Exclusion Criteria
  • Patients with mild dehydration.
  • Patients with history of significant comorbid conditions or previous laparotomy.
  • Congenital heart disease.
  • Heart failure.
  • Disorder of venous return like arteriovenous fistula, DVT or Varicose veins.
  • Increase intra-abdominal pressure.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of changes in the ratio of femoral vein diameter to femoral artery diameterimmediate preoperative period before the induction of general anesthesia

Measurement of changes in the ratio of femoral vein diameter to femoral artery diameter before and after fluid challenge which will be defined as infusion of ringer lactate 10 ml/kg body weight over 20 min.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of medicine, Tanta university

🇪🇬

Tanta, El Gharbyia, Egypt

© Copyright 2025. All Rights Reserved by MedPath